If you have questions, please call us for more information about clinical trials or use our online form.
- Cancer clinical trials: 414-805-8900
- Noncancer clinical trials: 414-955-8555
Learn more about clinical trials basics and early-phase clinical trials, as well as some of the unique features our research program, including our Translational Research Unit. Froedtert & MCW health network is also part of the National Institutes of Health All of Us Research Program.
Displaying 81 - 90 of 294
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Safety and Efficacy
of OMS721 in Patients with Immunoglobulin A (IgA) Nephropathy (ARTEMIS - IGAN)
Study of the Safety and Efficacy of OMS721 in Patients With Immunoglobulin A (IgA) Nephropathy
Protocol No
NEPH-ELMEANAWY-OMEROS2
Categories
Effects of Transcranial Direct Current Stimulation (tDCS) on Language
Effects of Transcranial Direct Current Stimulation (tDCS) on Language
Protocol No
NEURO-AHW-TDCS-LANGUAGE
Categories
A Multicenter, International, Randomized, Placebo Controlled, Double-Blind, Parallel Group And Event Driven Phase 3 Study Of The Oral Fxia Inhibitor Asundexian (BAY 2433334) For The Prevention Of Ischemic Stroke In Male And Female Participants Aged 1
A Study to Learn More About Asundexian (Also Called BAY2433334) for Prevention of Ischemic Stroke in Male and Female Participants Aged 18 Years and Older Who Already Had Such a Stroke Due to a Blood Clot That Formed Outside the Heart and Travelled to the Brain, or Temporary Stroke-like Symptoms
Protocol No
NEURO-BAYER-OCEANIC-STROKE
Categories
Effectiveness of Switching to Cladribine Tablets in Multiple Sclerosis Patients with High Disease Activity or Disease Breakthrough in a US Real-World Population (HDA Switch Study)
Cladribine Tablets in MS with High Disease Activity or Disease Breakthrough
Protocol No
NEURO-EMD-HDA-SWITCH
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Basket Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Patients With Anti-N-Methyl-D-Aspartic Acid Receptor (Nmdar) Or Anti-Leuci
Satralizumab in NMDAR or LGI1 Enchephalitis
Protocol No
NEURO-GENENTECH-CIELO
Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial (TREAT-MS)
Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial (TREAT-MS)
Protocol No
NEURO-JH-TREAT-MS
Exogenous Tuning of Neural Oscillations as a Mode of Treatment in Post-stroke Subacute Aphasia
Transcranial Alternating Current Stimulation (tACS) in Subacute Aphasia
Protocol No
NEURO-MCW-TACS-SUBACUTEAPHASIA
Categories
Concept Representation in the Human Brain
Concept Representation in the Human Brain
Protocol No
NEURO-NIH-CONCEPT-REP-BRAIN
The Intersection of GLP-1, Gut Microbiota, and Brain Connectivity in Prodromal Alzheimer's Disease
GLP-1, Gut Microbiota, and Brain Connectivity in AD
Protocol No
NEURO-NIH-MICROBIOME-GLP-1-AD
Anticoagulation in Intracerebral Hemorrhage Survivors for Stroke Prevention and Recovery
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery (ASPIRE)
Protocol No
NEURO-NINDS-ASPIRE
Categories